Orbus Pharma Inc.

Orbus Pharma Inc.

October 03, 2005 19:42 ET

Orbus Announces Exercise Of Warrants

TORONTO, ONTARIO--(CCNMatthews - Oct. 3, 2005) - Orbus Pharma Inc. (TSX:ORB)("Orbus") today announced that 604,200 warrants to acquire an equivalent number of common shares were exercised at $0.75 each on September 30th 2005 for total net proceeds of $453,150.

Orbus Pharma Inc., headquartered in Markham, Ontario and listed on The Toronto Stock Exchange under the symbol ORB pursues a strategy of generating revenue through the licensing of our generic drug developments as well as the manufacturing and selling of pharmaceutical products.

Contact Information

  • Orbus Pharma Inc.
    Denis C. Arsenault
    V.P. Finance & CFO
    (905) 943-9444 Ext 222